AMA recommends Vitamin D testing

The American Medical News, a news publication for physicians published by the American Medical Association, is encouraging physicians to perform Vitamin D testing!

Natural Vitamin D intake from both dietary sources and sunlight could be a lot less than we think, thus increasing the risk of vitamin deficiency. Therefore, testing may be an important way of uncovering Vitamin D deficiencies.

Supplementing a healthy diet with additional vitamins can help protect against vitamin deficiencies and increase vitamin levels.

Res-Q Multi is a heart-healthy multivitamin that contains Vitamin D in the form of Vitamin D3.

Vitamin D3, also called cholecalciferol, is the best form of Vitamin D because it is the same form that the human body makes. However, due to the necessity of sunscreen to protect the skin from skin cancer and damaging burns, and the long winter months spent inside, our bodies may not be making enough.

Res-Q Product Website

For questions or to hear our current promotions, please call 1-800-26-ALIVE. (262-5484)

Email sales@n3inc.com

References:
AMA meeting: Vitamin D checks urged. June 29th 2009, American Medical News

New All-Natural Ways to Lower Your Cholesterol

It was recently reported on the news that a diet low in carbohydrates reduced cholesterol levels.

This diet may have been successful while others failed, because vegetable sources were used. Sometimes low carbohydrate diets can tend to be high in animal products which contribute to the intake of dietary cholesterol.

Many people struggle to maintain a normal cholesterol level. Dietary fluctuations could cause a good cholesterol number to increase.

However, the right natural products help maintain a cholesterol level that is already normal. Res-Q LDL-x2 with Niacin is a safe, all-natural product that contains an ingredient that is known to lower LDL cholesterol levels by blocking the absorption of dietary cholesterol in the digestive tract.

Res-Q LDL-x2 is also available without the added niacin. For complete heart health benefits, please take Res-Q LDL-x2 with Niacin, in conjunction with Res-Q 1250, our potent omega-3 supplement.

For more information on Res-Q LDL-x2 with Niacin and Res-Q 1250, visit us online at http://www.myresqproducts.com/, email us at sales@n3inc.com, or call one of our friendly Res-Q Consultants at 1-800-26 ALIVE.

References:
Plant-based, low-carb diet cuts body weight, improves lipid levels, Reuters Health, June 2009

Arch Intern Med 2009;169:1027,1046-1054.

Res-Q 1250 and Mental Health: Part I

The Omega-3 Fatty Acid EPA is Important to Mental Health

The increased prevalence of mental illness and the surge of new medications may indicate a greater need for prevention and the need to focus on the health of the brain.

Res-Q 1250, our high-potency omega-3 supplement, helps maintain a healthy mood. We include a healthy balance of both EPA and DHA, the building blocks of the brain, the majority of which is comprised of fats. Res-Q 1250 is effective because it is a direct source of the omega-3 fatty acids called EPA and DHA, the very same active ingredients that are identified in clinical studies published in the medical journals. Res-Q 1250 contains more EPA and DHA per capsule for less.

EPA Study
Patients diagnosed with major depression disorder were given the fatty acid EPA, medication, or EPA plus medication for 8 weeks. The combination of treatment with the omega-3 fatty acid EPA plus the medication was “significantly better” than either treatment alone. In conclusion, omega-3 supplements containing EPA are beneficial to the health of the brain. Furthermore, the fatty acid EPA is as important as DHA for complete mental health.

For more information, or to order please call toll free 1-800-26-ALIVE or visit us on the web.

References:

More Americans taking drugs for mental illness, Reuters, May 5th 2009.

Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder. Australian and New Zealand Journal of Psychiatry. March 2008